Christine Poon, J&J’s Highest-Ranking Woman, to Retire in March

Poon, 56, leaves at a time when J&J's drug business is a mess. Generics are sapping the the sales of some of the company's most important medicines. Most notably, the oral version of antipsychotic Risperal went generic in June and its patent-protected successor, Invega, has been a disappointment.